go-v.orgcodex
Menu
Page tools

codex · Chemistry

CA-170

Diagram for CA-170
CA-170 is an investigational new drug being evaluated as an immune checkpoint inhibitor for the treatment of cancer. Developed by Aurigene Oncology, it is an orally available small molecule designed to selectively inhibit the immune checkpoint proteins PD-L1 and VISTA. · image: Wikimedia Commons

CA-170 is an investigational new drug being evaluated as an immune checkpoint inhibitor for the treatment of cancer. Developed by Aurigene Oncology, it is an orally available small molecule designed to selectively inhibit the immune checkpoint proteins PD-L1 and VISTA.

Wikipedia contributors, "CA-170", Wikipedia, revision 1382839357, retrieved 20 November 2026, source, CC BY-SA 4.0.

More Chemistry · Search the codex